# Glycolipid recognition and binding by Siglec-6 hinges on interactions with the cell membrane

**Authors:** Silvia D’Andrea, Edward N. Schmidt, Duong Bui, Ojas Singh, Ling Han, Lara K. Mahal, John S. Klassen, Matthew S. Macauley, Elisa Fadda

PMC · DOI: 10.1038/s42003-026-09609-8 · Communications Biology · 2026-01-28

## TL;DR

The study reveals how Siglec-6 binds glycolipids by interacting with the cell membrane, expanding our understanding of immune regulation.

## Contribution

The paper identifies a novel binding mechanism for Siglec-6 that involves membrane interactions, not just sialic acid recognition.

## Key findings

- Siglec-6 uses phospholipid interactions to supplement binding free energy.
- Mutagenesis confirmed the importance of Lys 126 and Trp 127 for membrane binding.
- Siglec-6 adapts to its biological environment to recognize specific sialylation patterns.

## Abstract

Sialic acid-binding immunoglobulin-type lectins (Siglecs) regulate immune response through interactions with sialylated glycans on glycoproteins and glycolipids. Human Siglecs count 14 unique proteins and in all of those the recognition and binding of the sialic acid on the glycan target involves a conserved, or canonical, Arg residue. For a subset of human Siglecs, namely MAG, Siglec-6, and Siglec-11, this Arg appears not to be essential, suggesting that a different binding mechanism may be at play. In this work, we used all-atom molecular dynamics (MD) simulations, binding assays, and mutagenesis to investigate the structural, mechanistic and energetic details of the binding of Siglec-6 to monosialylated gangliosides. Our results show that Siglec-6 relies only partially on its conserved Arg122 for recognition of membrane-bound gangliosides and that it supplements its binding free energy through interactions with the phospholipids in the membrane surrounding the target epitope. We confirmed by mutagenesis assays that the loss of the key residues (Lys 126 and Trp 127) for membrane interaction abrogates binding. These results provide a step-change in our understanding of the diversification of human Siglecs as molecular precision tools to bind specific sialosides by adapting their structure to the biological environment where these are found.

Siglecs are immunoregulatory lectins with very similar architectures. The authors show how the V-set domain of Siglec-6 allows it to select for precise sialylation patterns in specific biological environments, recasting Siglecs as molecular precision tools

## Linked entities

- **Genes:** SIGLEC6 (sialic acid binding Ig like lectin 6) [NCBI Gene 946], SIGLEC11 (sialic acid binding Ig like lectin 11) [NCBI Gene 114132], MAG (myelin associated glycoprotein) [NCBI Gene 4099]
- **Proteins:** SIGLEC6 (sialic acid binding Ig like lectin 6), SIGLEC11 (sialic acid binding Ig like lectin 11), MAG (myelin associated glycoprotein)

## Full-text entities

- **Genes:** MAG (myelin associated glycoprotein) [NCBI Gene 4099] {aka GMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75}, SIGLEC6 (sialic acid binding Ig like lectin 6) [NCBI Gene 946] {aka CD327, CD33L, CD33L1, CD33L2, CDW327, OBBP1}, SIGLEC11 (sialic acid binding Ig like lectin 11) [NCBI Gene 114132]
- **Chemicals:** Trp (MESH:D014364), sialic acid (MESH:D019158), Glycolipid (MESH:D006017), gangliosides (MESH:D005732), Lys (MESH:D008239), glycan (MESH:D011134), phospholipids (MESH:D010743)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953582/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953582/full.md

---
Source: https://tomesphere.com/paper/PMC12953582